Search Results - "Botling, Johan"

The impact of re‐characterizing metastatic pancreatic neuroendocrine tumors: A prospective study.

Authors: Mollazadegan, Kazhan Botling, Johan Skogseid, Britt et al.

Source: Journal of Neuroendocrinology. Aug2025, Vol. 37 Issue 8, p1-9. 9p.

Gene expression-based identification of prognostic markers in lung adenocarcinoma.

Authors: Salomonsson, Annette Ehinger, Daniel Jönsson, Mats et al.

Source: PLoS ONE. 5/7/2025, Vol. 20 Issue 5, p1-14. 14p.

Feasibility and outcome of genomics-guided treatment selection in advanced cancer - the MEGALiT explorative clinical trial.

Authors: Ny, Lars Fagman, Henrik Botling, Johan et al.

Source: Acta Oncologica. 2025, Vol. 64, p742-850. 9p.

Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer.

Authors: Elfving, Hedvig Yu, Hui Fessehatsion, Kaleab Kassete et al.

Source: Cellular Oncology (2211-3428). Jun2025, Vol. 48 Issue 3, p801-813. 13p.

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma.

Authors: Tholander, Bengt Koliadi, Anthoula Botling, Johan et al.

Source: Upsala Journal of Medical Sciences. Nov2020, Vol. 125 Issue 4, p325-329. 5p.

Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Authors: Dam, Gitte Grønbæk, Henning Sundlöv, Anna et al.

Source: Acta Oncologica. May2023, Vol. 62 Issue 5, p431-437. 7p. 1 Chart.

Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature.

Authors: Tsakonas, Georgios Koulouris, Andreas Kazmierczak, Dominika et al.

Source: International Journal of Molecular Sciences. Jan2023, Vol. 24 Issue 1, p193. 17p.

Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors.

Authors: Falkman, Lovisa Sundin, Anders Skogseid, Britt et al.

Source: Upsala Journal of Medical Sciences. 2024 Special Issue, Vol. 129, p1-7. 7p.

Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non‐small cell lung cancer.

Authors: Salomonsson, Annette Micke, Patrick Mattsson, Johanna S. M. et al.

Source: Cancer Medicine. Aug2020, Vol. 9 Issue 15, p5609-5619. 11p.

Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers: A Comprehensive Study and Review of the Literature.

Authors: Staaf, Johan Tran, Lena Söderlund, Linnea et al.

Source: Archives of Pathology & Laboratory Medicine. Sep2020, Vol. 144 Issue 9, p1075-1085. 11p. 2 Color Photographs, 1 Diagram, 4 Charts, 1 Graph.

Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.

Authors: Micke, Patrick Botling, Johan Mattsson, Johanna Sofia Margareta et al.

Source: Scientific Reports. 2/4/2019, Vol. 9 Issue 1, p1-1. 1p.

1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer.

Authors: Mayrhofer, Markus Göransson Kultima, Hanna Birgisson, Helgi et al.

Source: BMC Cancer. 2014, Vol. 14 Issue 1, p1-18. 18p. 1 Color Photograph, 2 Charts, 2 Graphs.

Epigenetics of lung cancer: a translational perspective.

Authors: Quintanal-Villalonga, Álvaro Molina-Pinelo, Sonia

Source: Cellular Oncology (2211-3428). Dec2019, Vol. 42 Issue 6, p739-756. 18p.

Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer.

Authors: Jabs, Verena Edlund, Karolina König, Helena et al.

Source: PLoS ONE. 11/07/2017, Vol. 12 Issue 11, p1-23. 23p.

High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC.

Authors: Tsakonas, Georgios Martín-Bernabé, Alfonso Rounis, Konstantinos et al.

Source: Cancers. Jul2021, Vol. 13 Issue 13, p3151-3151. 1p.

Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer.

Authors: Mattsson, Johanna S. M. Brunnström, Hans Jabs, Verena et al.

Source: BMC Cancer. 8/5/2016, Vol. 16, p1-15. 15p. 6 Diagrams, 3 Charts.

Identification of sample annotation errors in gene expression datasets.

Authors: Lohr, Miriam Hellwig, Birte Edlund, Karolina et al.

Source: Archives of Toxicology. Dec2015, Vol. 89 Issue 12, p2265-2272. 8p. 4 Charts, 4 Graphs.

LRIG1 is a prognostic biomarker in non-small cell lung cancer.

Authors: Kvarnbrink, Samuel Karlsson, Terese Edlund, Karolina et al.

Source: Acta Oncologica. Sep2015, Vol. 54 Issue 8, p1113-1119. 7p. 1 Color Photograph, 2 Charts.

Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer.

Authors: Birgisson, Helgi Edlund, Karolina Wallin, Ulrik et al.

Source: BMC Cancer. 2015, Vol. 15 Issue 1, p1-11. 11p.

In situ sequencing for RNA analysis in preserved tissue and cells.

Authors: Ke, Rongqin Mignardi, Marco Pacureanu, Alexandra et al.

Source: Nature Methods. Sep2013, Vol. 10 Issue 9, p857-860. 4p.